[Explainer] integration decisions change your number more than the sample does
The one-line version is the title: integration decisions change your number more than the sample does. The rest is why. Carryover from a previous high-concentration injection looks exactly like a small impurity. The blank injection is four minutes and it removes the ambiguity entirely. Gave the same trace to two…
Push back: a longer run is not automatically better resolution. You are trading peak width for time and the ratio is what matters.
Mass spectrometry answers identity. UV purity answers relative quantity under the run conditions. A document with one and not the other is answering half the question, and the half it answers should be stated.
Careful — you are treating retention time as identity. Two things can co-elute and the trace will not tell you.
area percent is relative to what the detector saw and nothing else
UV response is not uniform across species. At 214nm you are looking at the peptide bond, which is why it is the working wavelength for this class; at 280nm you only see tryptophan, tyrosine and phenylalanine.
214nm sees the peptide bond, 280nm sees the aromatics
What wavelength, and what was the gradient?
What wavelength, and what was the gradient?
Disagreeing with this bit: that spread is ordinary inter-lab variance, not a disagreement about the material.
Disagree. Inter-lab spread of a point or two on this assay is ordinary and calling it a discrepancy misleads people.
reproducibility beats resolution if you only get one of them
Ran a blank after a high-concentration injection and found the carryover I had been calling an impurity.